Biostar Pharmaceuticals Inc Share Price Nasdaq
Equities
US0906782026
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2015 | 27.13M 2.26B | Sales 2016 | 2.38M 199M | Capitalization | 7.73M 644M |
---|---|---|---|---|---|
Net income 2015 | -25M -2.08B | Net income 2016 | -5M -417M | EV / Sales 2015 | 0.33 x |
Net Debt 2015 | 2.73M 228M | Net Debt 2016 | 2.15M 179M | EV / Sales 2016 | 4.14 x |
P/E ratio 2015 |
-0.25
x | P/E ratio 2016 |
-1.17
x | Employees | - |
Yield 2015 * |
-
| Yield 2016 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Rong Hua Wang
CEO | Chief Executive Officer | 69 | 27/07/27 |
Xiaojuan Zhai
DFI | Director of Finance/CFO | - | 05/17/05 |
Zheng Hong Wang
COO | Chief Operating Officer | 43 | 01/12/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rong Hua Wang
CEO | Chief Executive Officer | 69 | 27/07/27 |
Hai Peng Wu
BRD | Director/Board Member | 66 | 01/07/01 |
Zhan Xiang Ma
BRD | Director/Board Member | - | 29/18/29 |
1st Jan change | Capi. | |
---|---|---|
+32.36% | 694B | |
+29.72% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.42% | 239B | |
-3.48% | 209B | |
+10.10% | 209B | |
+9.27% | 169B |